1. Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐HCl–UVA (Intercept™) over a 5‐year period of extensive delivery. Issue 4 (29th May 2015) Authors: Bost, V.; Chavarin, P.; Boussoulade, F.; Fabrigli, P.; Chabre, C.; Benamara, H.; Odent‐Malaure, H.; Legrand, D.; Cognasse, F.; Garraud, O. Journal: Vox sanguinis Issue: Volume 109:Issue 4(2015) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗